Teradyne Q2 Beat Fails to Quell Overvaluation Concerns

What happened

Teradyne posted Q2 GAAP EPS of $2.38 on revenue of $1.33 billion, comfortably above management's prior guidance of $1.15–$1.25 billion, yet the stock remains burdened by a stretched valuation. The DeepValue master report pegs base-case implied value at $430 versus the current price near $463, highlighting that even a beat doesn't close the gap. Management earlier cautioned that AI-related demand would represent the bulk of revenues only in the near term and guided gross margins to normalize to 58–59%, indicating peak profitability may be passing. The market continues to price a prolonged, smooth AI upcycle at 85x P/E and 94x EV/EBITDA, but the Q2 outperformance provides no assurance of durable, lump-free demand beyond the next quarter. Core risks—AI mix duration, acceptance timing volatility, and second-half weighting—remain unresolved.

Implication

The Q2 revenue beat does not alter the thesis that Teradyne is overvalued at 85x P/E. Management's own framing still points to AI demand being near-term concentrated and margins normalizing from peak levels, while the stock prices a long, smooth upcycle. Investors should treat any strength as an opportunity to trim, given the asymmetric risk of multiple compression if second-half demand or margins disappoint. Until the company extends AI visibility or the stock pulls back toward the $360 attractive entry, the risk/reward is unfavorable.

Thesis delta

The Q2 top-line beat modestly lifts near-term earnings power but does not resolve the core overvaluation risk. The DeepValue report's POTENTIAL SELL rating stands, as the stock still trades well above its base-case implied value of $430. The fundamental concern—that AI-related demand remains lumpy and management's own guidance suggests peak margins have passed—is unchanged.